viewBio-Rad Laboratories

Bio-Rad acquires QuantaLife in all-cash $162 million deal


Bio-Rad Laboratories (NYSE:BIO) announced Wednesday it has purchased QuantaLife in an all-cash deal worth $162 million, plus potential future milestones.

Under the terms of the transaction, Bio-Rad will receive QuantaLife's digital polymerase chain reaction (PCR) technology, which provides target molecules with precision and sensitivity.

The PCR system builds on the method of amplifying DNA, which is commonly used in laboratories across the globe. The digital PCR, however, is able to detect rare genetic mutations, and can precisely measure genetic variations, and absolutely quantify a gene's expression.

This makes the technology quite valuable to Bio-Rad, which manufactures and distributes a variety of clinical diagnostic products, it said.

Bio-Rad president and CEO, Norman Schwartz, commented: "We are impressed with QuantaLife's digital PCR technology and believe it will complement Bio-Rad's existing amplification business.

"This elegant solution expands the current state of the art methods of quantitative PCR (qPCR), and we look forward to its adoption in life science research."

Based in Hercules, California, Bio-Rad shares rose 1.57% to $93.92 as of 3:28 pm EDT.

Quick facts: Bio-Rad Laboratories

Price: 513.48 USD

Market: NYSE
Market Cap: $15.24 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Davide Bosio previews hotly anticipated IPOs for Miramar Resources and Zebit

Davide Bosio from Shaw and Partners says it's been a terrific start to the listing process for Miramar Resources, a junior West Australia exploration company. ''We opened up the offer and closed literally on the same day raising $8mln''. Bosio adds that Zebit is still on track to list on the ASX...

3 days, 1 hour ago

2 min read